BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 30840591)

  • 21. Comparison of microwave ablation and radiofrequency ablation for hepatocellular carcinoma: a systematic review and meta-analysis.
    Tan W; Deng Q; Lin S; Wang Y; Xu G
    Int J Hyperthermia; 2019; 36(1):264-272. PubMed ID: 30676100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiofrequency vs Microwave Ablation After Neoadjuvant Transarterial Bland and Drug-Eluting Microsphere Chembolization for the Treatment of Hepatocellular Carcinoma.
    Thornton LM; Cabrera R; Kapp M; Lazarowicz M; Vogel JD; Toskich BB
    Curr Probl Diagn Radiol; 2017; 46(6):402-409. PubMed ID: 28392205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microwave ablation versus radiofrequency ablation as bridge therapy in potentially transplantable patients with single HCC ≤ 3 cm: A propensity score-matched study.
    Wang X; Yu H; Zhao F; Xu Y; Wang C; Liu K; Liu B; Zheng H; Wei Y; Wang X; Zhu Q; Huang M; Feng Y
    Eur J Radiol; 2023 Jul; 164():110860. PubMed ID: 37178491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microwave ablation is as effective as radiofrequency ablation for very-early-stage hepatocellular carcinoma.
    Xu Y; Shen Q; Wang N; Wu PP; Huang B; Kuang M; Qian GJ
    Chin J Cancer; 2017 Jan; 36(1):14. PubMed ID: 28103953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiofrequency Ablation and Microwave Ablation in Liver Tumors: An Update.
    Izzo F; Granata V; Grassi R; Fusco R; Palaia R; Delrio P; Carrafiello G; Azoulay D; Petrillo A; Curley SA
    Oncologist; 2019 Oct; 24(10):e990-e1005. PubMed ID: 31217342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and efficacy of microwave versus radiofrequency ablation for large hepatic hemangioma: a multicenter retrospective study with propensity score matching.
    Kong J; Gao R; Wu S; Shi Y; Yin T; Guo S; Xin Z; Li A; Kong X; Ma D; Zhai B; Sun W; Gao J
    Eur Radiol; 2022 May; 32(5):3309-3318. PubMed ID: 35091785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microwave ablation versus radiofrequency ablation for perivascular hepatocellular carcinoma: a propensity score analysis.
    Feng Y; Wang L; Lv H; Shi T; Xu C; Zheng H; Qi J; Zhao X; Li J; Gao Y; Qin C; Zhu Q
    HPB (Oxford); 2021 Apr; 23(4):512-519. PubMed ID: 32839089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The (Eternal) Debate on Microwave Ablation
    Ricci AD; Rizzo A; Bonucci C; Tavolari S; Palloni A; Frega G; Mollica V; Tober N; Mazzotta E; Felicani C; Serra C; Brandi G
    In Vivo; 2020; 34(6):3421-3429. PubMed ID: 33144450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of Laparoscopic Microwave to Radiofrequency Ablation of Small Hepatocellular Carcinoma (≤3 cm).
    Santambrogio R; Chiang J; Barabino M; Meloni FM; Bertolini E; Melchiorre F; Opocher E
    Ann Surg Oncol; 2017 Jan; 24(1):257-263. PubMed ID: 27581608
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complications of thermal ablation of hepatic tumours: comparison of radiofrequency and microwave ablative techniques.
    Ding J; Jing X; Liu J; Wang Y; Wang F; Wang Y; Du Z
    Clin Radiol; 2013 Jun; 68(6):608-15. PubMed ID: 23399463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and Efficacy of Irreversible Electroporation for the Treatment of Hepatocellular Carcinoma Not Amenable to Thermal Ablation Techniques: A Retrospective Single-Center Case Series.
    Sutter O; Calvo J; N'Kontchou G; Nault JC; Ourabia R; Nahon P; Ganne-Carrié N; Bourcier V; Zentar N; Bouhafs F; Sellier N; Diallo A; Seror O
    Radiology; 2017 Sep; 284(3):877-886. PubMed ID: 28453431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of combination therapies in the management of locally advanced pancreatic cancer: Induction chemotherapy followed by irreversible electroporation vs radiofrequency ablation.
    He C; Wang J; Zhang Y; Cai Z; Lin X; Li S
    Cancer Med; 2020 Jul; 9(13):4699-4710. PubMed ID: 32410380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of Chronologic Change in the Size and Contrast-Enhancement of Ablation Zones on CT Images after Irreversible Electroporation and Radiofrequency Ablation.
    Scheck J; Bruners P; Schindler D; Kuhl C; Isfort P
    Korean J Radiol; 2018; 19(4):560-567. PubMed ID: 29962862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term outcomes of microwave versus radiofrequency ablation for hepatocellular carcinoma by surgical approach: A retrospective comparative study.
    Lee KF; Wong J; Hui JW; Cheung YS; Chong CC; Fong AK; Yu SC; Lai PB
    Asian J Surg; 2017 Jul; 40(4):301-308. PubMed ID: 26922631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pain analysis in patients with hepatocellular carcinoma: irreversible electroporation versus radiofrequency ablation-initial observations.
    Narayanan G; Froud T; Lo K; Barbery KJ; Perez-Rojas E; Yrizarry J
    Cardiovasc Intervent Radiol; 2013 Feb; 36(1):176-82. PubMed ID: 22752100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systematic review and meta-analysis of local ablative therapies for resectable colorectal liver metastases.
    Di Martino M; Rompianesi G; Mora-Guzmán I; Martín-Pérez E; Montalti R; Troisi RI
    Eur J Surg Oncol; 2020 May; 46(5):772-781. PubMed ID: 31862133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Irreversible electroporation of hepatocellular carcinoma: the role of ultrasonography.
    Sugimoto K; Abe M; Yoshimasu Y; Takeuchi H; Kasai Y; Itoi T
    Ultrasonography; 2020 Jul; 39(3):229-237. PubMed ID: 32450674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiofrequency ablation versus microwave ablation for early stage hepatocellular carcinoma: A PRISMA-compliant systematic review and meta-analysis.
    Han J; Fan YC; Wang K
    Medicine (Baltimore); 2020 Oct; 99(43):e22703. PubMed ID: 33120763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel irreversible electroporation ablation (Nano-knife) versus radiofrequency ablation for the treatment of solid liver tumors: a comparative, randomized, multicenter clinical study.
    Zhang X; Zhang X; Ding X; Wang Z; Fan Y; Chen G; Hu X; Zheng J; Xue Z; He X; Zhang X; Wei Y; Zhang Z; Li J; Li J; Yang J; Xue X; Ma L; Xiao Y
    Front Oncol; 2022; 12():945123. PubMed ID: 36249062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Irreversible Electroporation versus Radiofrequency Ablation: Comparison of Systemic Immune Responses in Patients with Hepatocellular Carcinoma.
    Sugimoto K; Kakimi K; Takeuchi H; Fujieda N; Saito K; Sato E; Sakamaki K; Moriyasu F; Itoi T
    J Vasc Interv Radiol; 2019 Jun; 30(6):845-853.e6. PubMed ID: 31126596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.